Diagnostics; making a difference


All Party Parliamentary Group for Life Sciences Launch

Monday saw the launch of the All Party Parliamentary Group for Life Sciences in the House of Commons. BIVDA gives an overview of the day.

Read the rest of entry »

China as an Export Market

China is viewed as one of the world’s most lucrative export markets by almost all sectors, and this is no less true for the health and life sciences industry. We take a look at the growing IVD market in in this rising global power.

Read the rest of entry »

Parliamentary Links Day 2015

The science and technology community descended upon Portcullis House along with several MPs for Parliamentary Links Day 2015, hosted by the Society of Biology. BIVDA were there and give an overview of the day in this week's blog.

Read the rest of entry »

Cervical Cancer Week - Guest Blog from Jo's Trust

It’s Cervical Cancer Awareness week (15-21 June), and today guest blogger Robert Music, Chief Executive at Jo’s Cervical Cancer Trust, tells us about the importance of screening, and how we can potentially reduce the number of women diagnosed with cervical cancer from 1000s to only 100s in the not too distant future and eventually see the eradication of the disease.

Jo’s Cervical Cancer Trust is the only UK charity dedicated to women and their families affected by cervical cancer and cervical abnormalities. They offer information and support to patients and their families, while raising awareness about how cervical cancer can be prevented and campaign for best care and treatment. 


Read the rest of entry »

Testing the new Government - a diagnostics perspective on GE2015

As we enter the calm after the storm of an election period, it will be back to business for the newly elected Conservative majority Government.

Read the rest of entry »

Diagnosing cancer earlier saves lives

Cancer Research UK is the world’s largest cancer charity, raising awareness and funding research into the prevention, diagnosis and treatment of the disease. In this article, Matthew Wickenden, Early Diagnosis Manager at Cancer Research UK tells us about the importance of early diagnosis for cancer outcomes, what Cancer Research UK are doing in this field, and how the UK can improve its standing on the international stage.

Part of our Guest Blogs Series 

Read the rest of entry »

BIVDA Chief Exec addresses Parliamentary and Scientific Committee

Doris-Ann Williams MBE, CEO of BIVDA  presented to MPs at the latest meeting of the Parliamentary and Scientific Committee, which focused on life sciences in the UK. Welcomed to the meeting by Chair, Andrew Miller MP, Doris-Ann was joined by Professor Guy Poppy, Chief Scientific Adviser at the Food Standards Agency, and Dr Malcolm Skingle CBE, Director, Academic Liaison, GlaxoSmithKline.    With a wide range of parliamentarians, academics and industry members in the audience, Doris-Ann gave an introduction to diagnostics. She outlined where diagnostics are used and the importance that they play throughout the patient pathway; diagnosing (or ruling out diagnosis), monitoring, screening and predicting/preventing illness. She also gave case studies showing their necessity to healthcare, as well as examples of tests, and how they can combat the ‘grand challenges’ of the day, free up NHS resource and meet previously unmet clinical need.  “The upcoming years may well b ...

Read the rest of entry »

New NICE Guidance for Diabetes

NICE have issued two draft guidelines on diabetes care. Of the two documents, one focuses on adults with type 1 diabetes and the other concentrates on children and young adults, with either type 1 or type 2.  Sparking this call for updated guidance, the last was issued in 2004, is the worrying evidence that rates of diabetes diagnosis are swelling profusely throughout the country. Research shows that there are over 370,000 type 1 diabetes sufferers across the country, and 450 children with type 2.  The guidance for adults focuses on greater personalisation of care, and encourages a structured education program for diabetes sufferers to improve understanding. It also specifies achievable individualised targets for HbA1c levels and plasma glucose. The guidance supports testing at least 4 times a day on a routine basis for blood glucose and up to ten times if the patient fulfils any further conditions e.g. before and after sport, if they aren’t achieving HbA1c targets, during illness, pregn ...

Read the rest of entry »

Diagnostics; tackling the spread of AMR

Antimicrobial Resistance has been a hot topic in the news again this week, as two reports have been released reviewing the AMR situation as it stands. The first annual progress report following the Government’s five year strategy 2013-18 into AMR has been issued, available here.  The report sets out what work is underway and some important achievements in the first year of the Strategy including: • establishing baseline data to improve the way we monitor antibiotic prescribing and trends in resistance • publishing antimicrobial prescribing quality measures • launching an Antibiotic Guardian campaign (during European Antibiotic Awareness Day) • improving the coordination of research into AMR • leading the development of a new World Health Organisation (WHO) resolution on AMR • establishing an independent Review on AMR The Antibiotic Guardian Campaign took place on European Antibiotic Awareness Day, which BIVDA were able to also contribute. You can find ...

Read the rest of entry »

Increasing access to diagnostics hits the headlines again

Increasing access to diagnostics hits the headlines again Today (27 November, 2014) a commission established by the Lancet has reported that liver disease stands out as a glaring exception to the vast improvements made during the past 30 years in health and life expectancy for chronic disorders such as stroke, heart disease and many cancers. There are many striking things about this wide ranging and detailed report, but none more shocking than the fact that since the 1970s mortality rates from liver disease have increased 400 per cent, and in people younger than 65 years has risen by almost five-times.  To combat this increasing problem the commission, led by Prof Roger Williams, director of the Institute of Hepatology, calls for radical changes in the diagnosis of liver disease. Of particular interest, the report suggests that standard liver function tests provided in UK laboratories aren’t helping to detect early liver damage.  It also highlights that knowledge and awareness of liver dis ...

Read the rest of entry »

Pages: Previous1234567NextReturn Top